Management of Pachymeningitis in a Young Girl
In this young girl with MRI-confirmed pachymeningitis over the left frontal and right temporal convexities, immediate neurology consultation, comprehensive etiological workup including lumbar puncture with infectious and inflammatory studies, and empirical high-dose corticosteroid therapy (methylprednisolone 1g IV daily for 3-5 days) should be initiated while awaiting definitive diagnosis, with consideration of empirical antimicrobial coverage until infection is excluded.
Immediate Diagnostic Workup
The evaluation must systematically exclude infectious, inflammatory, and neoplastic etiologies before committing to long-term immunosuppression 1, 2.
Essential Investigations
Cerebrospinal fluid analysis is critical and should include:
- Opening pressure measurement
- Cell count with differential (expect lymphocytic pleocytosis in 50% of cases, elevated protein in 50-70%)
- Glucose level (compare to serum glucose obtained simultaneously)
- Gram stain, bacterial and fungal cultures
- PCR for HSV, VZV, tuberculosis, and other viral pathogens based on epidemiology
- Cytology to exclude leptomeningeal malignancy
- Consider oligoclonal bands if autoimmune etiology suspected 3, 4
Serum studies should encompass:
- ESR and CRP (elevated in >90% of inflammatory pachymeningitis cases)
- ANCA panel (both PR3 and MPO antibodies - ANCA-associated pachymeningitis presents with headache and cranial neuropathies in 89% with systemic involvement) 5
- IgG4 levels (IgG4-related disease accounts for increasing proportion of previously "idiopathic" cases) 6
- ACE level and chest imaging for sarcoidosis
- Infectious serologies: syphilis (RPR/VDRL, FTA-ABS), tuberculosis (QuantiFERON or PPD), HIV
- Autoimmune panel: ANA, RF, complement levels
- Complete blood count, comprehensive metabolic panel 1, 7
Advanced imaging should include:
- Contrast-enhanced MRI with attention to pattern and extent of dural enhancement
- MRV to exclude cerebral venous thrombosis (can mimic pachymeningitis radiographically) 8
- Chest CT to evaluate for sarcoidosis, tuberculosis, or granulomatosis with polyangiitis 2
Role of Meningeal Biopsy
Meningeal biopsy should be strongly considered if the initial workup is unrevealing after 2-4 weeks of investigation, particularly given the young age and need for definitive diagnosis 7, 9. The biopsy can identify:
- Granulomatous inflammation (tuberculosis, sarcoidosis)
- IgG4-positive plasma cell infiltration with storiform fibrosis
- Vasculitis patterns
- Neoplastic infiltration
- Infectious organisms on special stains
However, recognize that biopsy may be non-diagnostic in up to 34% of cases, showing only nonspecific chronic inflammation 10, 7.
Initial Management Strategy
Empirical Antimicrobial Coverage
Start IV acyclovir empirically (10 mg/kg every 8 hours) until HSV PCR returns negative, given the overlap with viral meningitis/encephalitis presentations 3, 4.
Consider empirical antibacterial therapy until bacterial cultures are finalized, particularly if CSF shows neutrophilic predominance or if the patient appears systemically ill 3.
Tuberculosis treatment should be initiated empirically in endemic areas or with suggestive CSF findings (lymphocytic pleocytosis, low glucose, very high protein) while awaiting mycobacterial cultures, as delay significantly worsens prognosis 11, 9.
Corticosteroid Therapy
Once infectious etiologies are reasonably excluded (negative Gram stain, negative HSV PCR, no clinical suspicion for active tuberculosis):
Initiate methylprednisolone 1g IV daily for 3-5 days 12, 3. This aggressive approach is justified because:
- Untreated pachymeningitis leads to progressive neurologic deterioration and vision loss 7
- Corticosteroids improve headache in 90% and vision in 87.5% of cases 7
- Early treatment prevents irreversible cranial nerve damage
Transition to oral prednisone 1 mg/kg/day after pulse therapy, with a slow taper over 4-6 weeks minimum 12, 3. Monitor closely for symptom recurrence during taper.
Common Pitfall
Do not delay corticosteroids excessively while pursuing exhaustive workup if infection has been reasonably excluded - the window for reversing neurologic deficits is narrow, and vision loss may become permanent 10, 7.
Etiology-Specific Considerations
IgG4-Related Disease
If serum IgG4 is elevated (>135 mg/dL) and biopsy confirms IgG4-positive plasma cells with storiform fibrosis:
- Continue high-dose corticosteroids as above
- Consider rituximab (375 mg/m² weekly for 4 weeks) for steroid-refractory cases or to enable steroid-sparing 6
- Long-term maintenance immunosuppression is typically required
ANCA-Associated Vasculitis
If ANCA-positive (particularly with systemic features like ENT involvement, pulmonary nodules, or renal disease):
- Combine corticosteroids with cyclophosphamide (2 mg/kg/day oral or 15 mg/kg IV monthly) or rituximab
- Rituximab shows lower rates of refractory disease (25% of cases in recent series) 5
- Relapse rate remains 23.5% at median 9-month follow-up, necessitating prolonged monitoring
Idiopathic Pachymeningitis
If workup remains negative after extensive investigation (occurs in 16.7% of cases) 11:
- Proceed with corticosteroid therapy as outlined
- Add steroid-sparing agent (methotrexate 15-25 mg weekly or azathioprine 2 mg/kg/day) if symptoms recur with steroid taper, which occurs in 50% of cases 7
- Serial MRI every 3-6 months correlates 80% with clinical state and guides treatment adjustments 7
Monitoring and Follow-Up
- Clinical reassessment weekly during initial treatment phase
- MRI at 3 months to assess treatment response (imaging improvement correlates with clinical improvement in 80% of cases) 7
- Monitor for steroid complications: glucose intolerance, hypertension, osteoporosis prophylaxis with calcium/vitamin D
- Long-term surveillance for relapse, which occurs in 23.5-50% of cases depending on etiology 7, 5
Critical Caveats
Mortality risk is 3.9% overall but higher with delayed diagnosis or CNS complications 5. Incomplete neurologic recovery occurs in a substantial proportion despite treatment, particularly with vision loss 10, 7. Therefore, aggressive early intervention is paramount to prevent irreversible deficits in this young patient.